ELION THERAPEUTICS Trademark

Trademark Overview


On Wednesday, December 6, 2023, a trademark application was filed for ELION THERAPEUTICS with the United States Patent and Trademark Office. The USPTO has given the ELION THERAPEUTICS trademark a serial number of 98301402. The federal status of this trademark filing is NON-FINAL ACTION - MAILED as of Friday, July 5, 2024. This trademark is owned by Sfunga Therapeutics, Inc.. The ELION THERAPEUTICS trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Pharmaceutical research and development; Research and development of medications administered by a healthcare professional in a healthcare setting for systemic fungal infections or invasive fungal disease; Providing scientific information on the disease state and treatment of invasive fungal infections and invasive fungal disease; Providing a website featuring scientific information about the disease state and treatment of invasive fungal infections and invasive fungal disease

General Information


Serial Number98301402
Word MarkELION THERAPEUTICS
Filing DateWednesday, December 6, 2023
Status641 - NON-FINAL ACTION - MAILED
Status DateFriday, July 5, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesPharmaceutical research and development; Research and development of medications administered by a healthcare professional in a healthcare setting for systemic fungal infections or invasive fungal disease; Providing scientific information on the disease state and treatment of invasive fungal infections and invasive fungal disease; Providing a website featuring scientific information about the disease state and treatment of invasive fungal infections and invasive fungal disease

Classification Information


International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateWednesday, December 6, 2023
Primary Code042
First Use Anywhere DateWednesday, January 10, 2024
First Use In Commerce DateWednesday, January 10, 2024

Trademark Owner History


Party NameELION THERAPEUTICS, INC.
Party Type11 - New Owner Before Publication
Legal Entity Type03 - Corporation
AddressNEW YORK, NY 10010

Party NameSfunga Therapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNew York, NY 10010

Trademark Events


Event DateEvent Description
Wednesday, December 6, 2023NEW APPLICATION ENTERED
Sunday, March 3, 2024NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, May 16, 2024AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Thursday, May 23, 2024AMENDMENT TO USE PROCESSING COMPLETE
Thursday, May 23, 2024USE AMENDMENT FILED
Thursday, May 23, 2024TEAS AMENDMENT OF USE RECEIVED
Friday, July 5, 2024USE AMENDMENT ACCEPTED
Friday, July 5, 2024NON-FINAL ACTION WRITTEN
Friday, July 5, 2024NON-FINAL ACTION E-MAILED
Friday, July 5, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, July 5, 2024ASSIGNED TO EXAMINER
Tuesday, September 3, 2024APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Tuesday, September 3, 2024APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED